Charles Schwab’s Xtrackers MSCI EAFE High Dividend Yield Equity ETF HDEF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$764M Sell
23,761,393
-1,861,202
-7% -$60.9M 0.1% 157
2026
Q1
$830M Sell
25,622,595
-1,968,024
-7% -$63.5M 0.13% 131
2025
Q4
$855M Sell
27,590,619
-1,780,992
-6% -$53.7M 0.13% 127
2025
Q3
$864M Sell
29,371,611
-1,779,865
-6% -$52.3M 0.14% 124
2025
Q2
$899M Sell
31,151,476
-3,319,200
-10% -$93M 0.16% 109
2025
Q1
$936M Buy
34,470,676
+814,198
+2% +$21.2M 0.18% 101
2024
Q4
$818M Sell
33,656,478
-966,138
-3% -$24.5M 0.15% 111
2024
Q3
$931M Buy
34,622,616
+4,612,965
+15% +$119M 0.18% 98
2024
Q2
$732M Buy
+30,009,651
New +$749M 0.14% 132

Other funds holding HDEF

Charles Schwab's HDEF Position: Q2 2026 in Review

Charles Schwab reduced its Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF) stake by 7.3% in Q2 2026, selling an estimated $60.9M and leaving 23,761,393 shares worth $764M. The position accounts for 0.1% of the portfolio, ranked #157.

Charles Schwab first reported a position in HDEF in Q2 2024 and has held it in 9 quarters since. The position peaked at $936M in Q1 2025. 139 funds tracked by Wall St. Rank hold HDEF as of Q2 2026.

  • Charles Schwab held 23,761,393 shares of Xtrackers MSCI EAFE High Dividend Yield Equity ETF worth $764M as of Q2 2026.
  • Charles Schwab sold 1,861,202 Xtrackers MSCI EAFE High Dividend Yield Equity ETF shares in Q2 2026, an estimated $60.9M.
  • Xtrackers MSCI EAFE High Dividend Yield Equity ETF made up 0.1% of Charles Schwab's portfolio in Q2 2026, its #157 holding.
  • Charles Schwab first reported a position in Xtrackers MSCI EAFE High Dividend Yield Equity ETF in Q2 2024 and has held it in 9 quarters since.
  • Charles Schwab's Xtrackers MSCI EAFE High Dividend Yield Equity ETF position peaked at $936M in Q1 2025.
  • 139 funds tracked by Wall St. Rank held Xtrackers MSCI EAFE High Dividend Yield Equity ETF as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.